Matches in Nanopublications for { ?s ?p "[Quantitative analysis of NMDAR2B promoter methylation showed 61% (17/28) hypermethylation in primary gastric tumors versus 5% (1/20) in normal gastric tissues from nongastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP173503.RAW98lc289fzPHqNIuoFdM6ZuERPtjCK4GMGsDgkNqtlM130_assertion description "[Quantitative analysis of NMDAR2B promoter methylation showed 61% (17/28) hypermethylation in primary gastric tumors versus 5% (1/20) in normal gastric tissues from nongastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173503.RAW98lc289fzPHqNIuoFdM6ZuERPtjCK4GMGsDgkNqtlM130_provenance.
- NP405778.RAVV7ucphT3l-9l2VeoZU4pOSPV9Kg6tc4Rg4Q1XGbUzc130_assertion description "[Quantitative analysis of NMDAR2B promoter methylation showed 61% (17/28) hypermethylation in primary gastric tumors versus 5% (1/20) in normal gastric tissues from nongastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405778.RAVV7ucphT3l-9l2VeoZU4pOSPV9Kg6tc4Rg4Q1XGbUzc130_provenance.
- NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_assertion description "[Quantitative analysis of NMDAR2B promoter methylation showed 61% (17/28) hypermethylation in primary gastric tumors versus 5% (1/20) in normal gastric tissues from nongastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_provenance.
- NP434629.RA9MOICMkQ6Xpj978KxcUCLrxzCAipsCqQLWBQWOwh2mI130_assertion description "[Quantitative analysis of NMDAR2B promoter methylation showed 61% (17/28) hypermethylation in primary gastric tumors versus 5% (1/20) in normal gastric tissues from nongastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434629.RA9MOICMkQ6Xpj978KxcUCLrxzCAipsCqQLWBQWOwh2mI130_provenance.
- assertion description "[Quantitative analysis of NMDAR2B promoter methylation showed 61% (17/28) hypermethylation in primary gastric tumors versus 5% (1/20) in normal gastric tissues from nongastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP619247.RAyyL4pD-KgKc0k8sayp3lOA8KxLve5DOaZ842OGljKio130_assertion description "[Quantitative analysis of NMDAR2B promoter methylation showed 61% (17/28) hypermethylation in primary gastric tumors versus 5% (1/20) in normal gastric tissues from nongastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619247.RAyyL4pD-KgKc0k8sayp3lOA8KxLve5DOaZ842OGljKio130_provenance.
- NP434659.RAMSo9QhK0r1_Q9CszmQZlw9sEGSb02FEenrwuloHb1A4130_assertion description "[Quantitative analysis of NMDAR2B promoter methylation showed 61% (17/28) hypermethylation in primary gastric tumors versus 5% (1/20) in normal gastric tissues from nongastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434659.RAMSo9QhK0r1_Q9CszmQZlw9sEGSb02FEenrwuloHb1A4130_provenance.